VRX Related Rumors
-
Valeant (VRX) Stock Surge Bodes Well for 2nd-Half M&A
-
Cooper Companies (COO) Rises on Bausch & Lomb Takeover Reports
-
Valeant (VRX) Continues Deal Hunt; Close to Buying Bausch & Lomb for $9B
-
UPDATE: Bausch & Lomb near deal to sell to Valeant Pharmaceuticals (VRX) - WSJ
-
Valeant (VRX), Mylan (MYL) on Watch as Actavis (ACT) Buys Warner Chilcott (WCRX)
-
UPDATE: Correct: Buying Warner Chilcott plc (WCRX) Seen as Takeover Defense by Actavis (ACT)
-
Warner Chilcott (WCRX) Volatile as Actavis (ACT) Has a New Bidder
-
Valeant (VRX) Volatile as Actavis (ACT) Seeks Its Own Deal
-
Actavis (ACT) / Valeant (VRX) Deal Rumored Down But Not Out
-
Valeant Pharmaceuticals (VRX) Near Deal to Acquire Actavis (ACT) for Over $13B
-
Options Whittling Down for Endo Health (ENDP) as CEO Holveck Departs
-
Endo Pharma (ENDP) Possibly in Talks to Sell Itself - Reuters
-
Analyst Says Obagi (OMPI) Could Soon See Offers from 'Multiple Suitors'
-
Medicis (MRX) Shares Jump 13% Following Rumors of Deal with Valeant (VRX)
-
Valeant (VRX) Approached Medicis Pharma (MRX) About Potential Sale -WSJ
-
Valeant Pharmaceuticals (VRX) Slammed After Losing Cephalon (CEPH) Bidding
-
Cephalon (CEPH) Will Respond to Valeant (VRX) Offer Within 24 Hours, Likely to Reject -CNBC
-
Takeover Target Cephalon (CEPH) Moves to Highs
-
Cephalon (CEPH) will resume trading at 7:10AM after takeover bid
-
Biotech Stocks Could See Action On Valeant (VRX) Bid for Cephalon (CEPH): (BIIB) (JAZZ) (DNDN) (REGN) (more...)
Back to VRX Stock Lookup
